Vivodyne to Replace Animal Testing With $40 Million Funding to Reverse 95% Clinical Trial Failure Rate
95% of clinical trials fail because animal testing is no substitute for human biology – Vivodyne’s robotics platform grows thousands of human tissues daily, directly tackling the biological gap behind clinical failures. Vivodyne’s AI generates clinically predictive human datasets, already in use by most of the world’s top pharmaceutical firms. Series A, led by Khosla … [Read more…]